Boosting drug named entity recognition using an aggregate classifier  by Korkontzelos, Ioannis et al.
BI
a
1
b
M
c
F
a
K
N
G
a
N
G
s
D
1
b
v
s
p
(
h
0Artiﬁcial Intelligence in Medicine 65 (2015) 145–153
Contents lists available at ScienceDirect
Artiﬁcial  Intelligence  in  Medicine
j o ur na l ho mepage: www.elsev ier .com/ locate /a i im
oosting  drug  named  entity  recognition  using  an  aggregate  classiﬁer
oannis  Korkontzelosa,∗, Dimitrios  Piliourasa,  Andrew  W.  Dowseyb,c, Sophia  Ananiadoua
National Centre for Text Mining (NaCTeM), School of Computer Science, The University of Manchester, Manchester Institute of Biotechnology,
31  Princess Street, Manchester M1 7DN, United Kingdom
Centre for Endocrinology and Diabetes, Institute of Human Development, Faculty of Medical and Human Sciences, The University of Manchester,
anchester, United Kingdom
Centre for Advanced Discovery and Experimental Therapeutics (CADET), The University of Manchester and Central Manchester University Hospitals NHS
oundation Trust, Manchester Academic Health Sciences Centre, Oxford Road, Manchester M13 9WL, United Kingdom
 r  t  i  c  l  e  i  n  f  o
eywords:
amed entity annotation sparsity
old-standard vs. silver-standard
nnotations
amed entity recogniser aggregation
enetic-programming-evolved
tring-similarity patterns
rug named entity recognition
a  b  s  t  r  a  c  t
Objective:  Drug  named  entity  recognition  (NER)  is a  critical  step  for complex  biomedical  NLP  tasks
such  as  the  extraction  of  pharmacogenomic,  pharmacodynamic  and  pharmacokinetic  parameters.  Large
quantities of high  quality  training  data  are  almost  always  a  prerequisite  for  employing  supervised
machine-learning  techniques  to achieve  high  classiﬁcation  performance.  However,  the human  labour
needed to produce  and maintain  such  resources  is a  signiﬁcant  limitation.  In this  study,  we  improve the
performance  of  drug  NER  without  relying  exclusively  on manual  annotations.
Methods:  We  perform  drug  NER  using  either  a small  gold-standard  corpus  (120  abstracts)  or  no corpus
at  all.  In our  approach,  we  develop  a voting  system  to  combine  a number  of heterogeneous  models,
based  on  dictionary  knowledge,  gold-standard  corpora  and  silver  annotations,  to enhance  performance.
To  improve  recall,  we employed  genetic  programming  to evolve  11  regular-expression  patterns  that
capture  common  drug  sufﬁxes  and  used  them  as  an  extra  means  for recognition.
Materials:  Our  approach  uses  a  dictionary  of drug  names,  i.e. DrugBank,  a small  manually  annotated
corpus,  i.e.  the pharmacokinetic  corpus,  and  a part  of  the UKPMC  database,  as  raw  biomedical  text.
Gold-standard  and  silver  annotated  data  are  used  to train  maximum  entropy  and  multinomial  logistic
regression  classiﬁers.
Results: Aggregating  drug  NER  methods,  based  on  gold-standard  annotations,  dictionary  knowledge  and
patterns,  improved  the  performance  on models  trained  on  gold-standard  annotations,  only,  achieving
a  maximum  F-score  of 95%.  In addition,  combining  models  trained  on  silver  annotations,  dictionary
knowledge  and  patterns  are  shown  to achieve  comparable  performance  to  models  trained  exclusively
on  gold-standard  data.  The  main  reason  appears  to be  the  morphological  similarities  shared  among  drug
names.
Conclusion:  We  conclude  that  gold-standard  data  are  not  a hard  requirement  for  drug  NER.  Combining
heterogeneous  models  build  on  dictionary  knowledge  can  achieve  similar  or comparable  classiﬁcation
performance  with  that of the best  performing  model  trained  on  gold-standard  annotations.
© 2015  The  Authors.  Published  by  Elsevier  B.V.  This  is  an open  access  article  under  the  CC  BY  license. Introduction
Named entity recognition (NER) is the task of identifying mem-
ers of various semantic classes, such as persons, mountains and
ehicles in raw text. In biomedicine, NER is concerned with classes
uch as proteins, genes, diseases, drugs, organs,  DNA sequences,  RNA
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sequences and possibly others [1]. Drugs (as pharmaceutical prod-
ucts) are special types of chemical substances highly relevant for
biomedical research. A simplistic and naive approach to NER is
to directly match textual expressions found in a relevant lexical
repository against raw text. Even though this technique can some-
times work well, often it suffers from certain limitations. Firstly,
its accuracy heavily depends on the completeness of the dictio-
nary. However, as terminology is constantly evolving, especially in
bio-related disciplines, producing a complete lexical repository
is not feasible. Secondly, direct string matching overlooks term
ambiguity and variability [2]. On one hand, ambiguous dictionary
entries refer to multiple semantic types (term ambiguity), and
nder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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herefore contextual information needs to be considered for dis-
mbiguation. On the other hand, several slightly different tokens
ay  refer to the same semantic type (term variability). Typically,
o address these issues, statistical learning models are deployed
or NER.
In such approaches, NER is formalised as a classiﬁcation task in
hich an input expression is either classiﬁed as an entity or not.
upervised learning methods are reported to achieve superior per-
ormance than unsupervised ones, but previously annotated data
re essential for training supervised models [2]. Data annotated by
uman curators are of high quality and guarantee best results in
xchange for the cost of manual effort. For these reasons, they are
lso known as gold-standard data. Due to the cost of manual anno-
ations, corpora for NER are often of limited size and for particular
omains.
Drugs are referred to by their chemical name, generic name or
rand name. Since the chemical name is typically complex and a
rand name may  not exclusively identify a drug once the relevant
atents expire, a unique non-proprietary name for the active ingre-
ient is devised for standardised scientiﬁc reporting and labelling.
his generic name is negotiated when the drug is approved for
se, as the nomenclature is tightly regulated by the World Health
rganization (WHO) and local agencies such as the U.S. Food and
rug Administration (FDA) and the European Medicines Agency.
everal criteria are assessed, such as ensuring the drug action
ts the naming scheme, ease of pronunciation and translation,
nd differentiation from other drug names to avoid transcription
nd reproduction errors during prescription [3]. Since the nam-
ng scheme, assessment criteria and cross-border synchrony have
eveloped organically over the years, there is neither a deﬁnitive
ictionary nor syntax of drug names.
In this study, we investigate methods for achieving high perfor-
ance in drug name recognition in cases where either very limited
r no gold-standard training data is available. Our proposed method
mploys a voting system able to combine predictions from a num-
er of diverse recognisers. Moreover, genetic programming is used
o evolve string-similarity patterns based on common sufﬁxes of
ingle-token drug names occurring in the DrugBank database [4].
ubsequently, these patterns are used to compile regular expres-
ions in order to generalise dictionary entries in an effort to increase
overage and tagging accuracy.
We  compare the performance of our method with several state-
f-the-art NER approaches in recognising manually annotated
rug names in the PK corpus [5]. Where no gold-standard data
s available, the proposed method is shown to achieve competi-
ive performance. In particular, the performance achieved without
old-standard data is comparable with the performance of the
odel aware of gold-standard annotations.
The rest of this paper is organised as follows: Section 2 sum-
arises previous work on drug NER and methods for dealing with
ata sparsity in general NER. Section 3 describes the dictionaries
nd data used in our experiments, as well as the experimen-
al methodology followed. Sections 4 and 5 present and discuss
he experiments and their results. Finally, section 6 concludes the
aper.
. Related work
NER is a large, well-studied ﬁeld of natural language processing
NLP) [6]. Most publications address it as a supervised task, i.e. the
rocedure of training a model on annotated data and then applying
t to new text. In the past, several evaluation challenges have taken
lace on recognising entities of the general domain [7–10] as well
s scientiﬁc domains [2,11,12]. In contrast, research related with
rug NER is limited [13–15]. Very recently, an evaluation challengece in Medicine 65 (2015) 145–153
that focussed exclusively on drug name recognition and drug-drug
interactions has taken place [16].
As a result of the collaborative annotation of a large biomedical
corpus project [17], a large-scale biomedical silver standard cor-
pus has been produced. It contains annotations resulting from the
harmonisation of named entities (NEs) automatically recognised
by ﬁve different tools, namely, Whatizit [18], Peregrine [19], GeNO
[20], MetaMap [21] and I2E [22]. Apart from names of chemicals
and drugs, proteins, genes, diseases and species names were also
tagged by these tools in the 174,999 MEDLINE abstracts comprising
the corpus. Approximately half a million NE annotations for each
semantic category are contained in the resulting harmonised cor-
pus which is publicly available. It has been used for the 2 annotation
challenges [23].
Dictionaries and ontologies have been used extensively as the
basis to generate patterns and rules for NER. Tsuruoka et al. [24]
used logistic regression to learn a string similarity measure from
a dictionary, useful for soft-string matching. Kolarik et al. [25]
used lexico-syntactic patterns to extract terms. Patterns are sim-
ilar to the ones introduced in [26] and contain drug names and
directly related drug annotation terms found in DrugBank. Then,
these patterns were applied to MEDLINE abstracts, to add anno-
tations of pharmacological effects of drugs. Similar methods have
also been applied for recognising drug-disease interactions [27] and
interactions between compounds and drug-metabolising enzymes
[28]. Hettne et al. [29] developed a rule-based method intended
for term ﬁltering and disambiguation. They identify names of
drugs and small molecules by incorporating several dictionaries
such as the UMLS (nlm.nih.gov/research/umls, accessed: 15 April
2015), MeSH (nlm.nih.gov/mesh, accessed: 15 April 2015), ChEBI
(www.ebi.ac.uk/chebi, accessed: 15 April 2015), DrugBank (drug-
bank.ca, accessed: 15 April 2015), KEGG (www.genome.jp/kegg,
accessed: 15 April 2015), HMDB (hmdb.ca, accessed: 15 April 2015)
and ChemIDplus (chem.sis.nlm.nih.gov/chemidplus, accessed: 15
April 2015). An earlier system, EDGAR [30], extracts genes, drugs
and relationships between them using existing ontologies and
standard NLP tools such as part-of-speech taggers and syntactic
parsers.
A popular means of dealing with data sparsity in NER is to
generate data semi-automatically or fully automatically. Although,
the resulting data is of lower quality than gold-standard annota-
tions, supervised learners can beneﬁt largely from large volumes
of data, since they are based on annotation statistics. Towards the
same ultimate goal, our approach aims to overcome the restric-
tions of data sparsity or unavailability in the biomedical domain.
Usami et al. [31] describe an approach for automatically acquir-
ing large amounts of training data from a lexical database and raw
text that relies on reference information and coordination analysis.
Similarly, noisy training data was  obtained by using a few man-
ually annotated abstracts from FlyBase (ﬂybase.org, accessed: 15
April 2015) [32,33]. The approach uses a bootstrapping method and
context-based classiﬁers to increase the number of NE mentions
in the original noisy training data. Even though they report high
performance, their method requires some minimum curated seed
data. Similarly, Thomas et al. [34] demonstrated the potential of
distant learning in constructing a fully automated relation extrac-
tion process. They produced two  distantly labelled corpora for
protein–protein and drug–drug interaction extraction, with knowl-
edge found in databases such as IntAct [35] for genes and DrugBank
[4] for drugs.
Active learning is a framework that can be used for reducing
the amount of human effort required to create a training cor-
pus [36,37]. The most informative samples are chosen from a big
pool of human annotations by a maximum likelihood model in an
iterative and interactive manner. It has been shown that active
learning can often drastically reduce the amount of training data
I. Korkontzelos et al. / Artiﬁcial Intelligen
Table  1
Binary token type features.
Token type features
initial capital letter contains hyphen
all lowercase letters contains slash
all  letters contains period
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ecessary to achieve the same level of performance compared to
ure random sampling [38]. A similar approach, accelerated anno-
ation [39], allows to produce NE annotations for a given corpus at
educed cost. In contrast to active learning, it aims to annotate all
ccurrences of the target NEs, thus minimising the sampling bias.
espite the similarities between the two frameworks, their goals
re different. While active learning aims to optimise the perfor-
ance of the corresponding tagger, accelerated annotation aims to
onstruct an unbiased NE annotated corpus.
. Methods and data
In this section we present our aggregate classiﬁer for recognising
rug names and the necessary resources.
.1. Methodology
To classify labels of tokens, we used two classiﬁers, a maximum
ntropy (MaxEnt) model, also known as multinomial logistic regres-
ion [40], and a perceptron classiﬁer [41]. MaxEnt classiﬁers assume
hat the best model parameters are the ones for which each fea-
ure’s predicted expectation matches its empirical expectation and
lassify instances so that the conditional likelihood is maximised.
n other words, MaxEnt maximises entropy while conforming to
he probability distribution drawn by the training set. Perceptron
s a linear classiﬁer that tunes the weights in a network during the
raining phase, so as to produce the desired output. The perceptron
ethod is guaranteed to locate the combination of weights that
olve the problem, if such a combination exists. We  used standard
mplementations of MaxEnt and Perceptron, parts of the Apache
penNLP project (opennlp.apache.org, accessed: 15 April 2015).
For both classiﬁers, we used the same feature set, described
elow. For each token, we consider as features:
 tokens: the current and ±2 tokens
 character n-grams: ±2 tokens
 sentence: a binary feature indicating whether the token appears
at start or end of a sentence
 binary token type features of the current and ±2 tokens, shown in
Table 1
 previous map: a binary feature indicating whether the current
token was previously seen as a NE
 preﬁx and sufﬁx of the current token
 dictionary:  a binary feature indicating whether the current token
exists in the dictionary
We  attempt to aggregate predictions from dictionaries and NER
ystems, under the fundamental hypothesis that the combined out-
ut might improve over the results of single classiﬁers deployed
s standalone. Our aggregate classiﬁer is compatible with any dic-
ionaries and recognition systems, and could be applied in other
omains and sequence recognition tasks.We developed a simple voting-system assuming that the predic-
ions of dictionaries are more reliable than predictions of machine
earners. As a result, the algorithm accepts dictionary predictions
s valid if they exist. This assumption is not true, if a dictionaryce in Medicine 65 (2015) 145–153 147
contains non-drug entities but, since dictionaries are produced
manually, we consider them ideal. Ambiguous NEs might also affect
the validity of this assumption. We  observed very little such ambi-
guities in our dictionary, DrugBank, thus, we  accept the hypothesis
to hold in the domain of drug NEs.
Algorithm 1 summarises the voting system. In short, it starts
with an empty list L and iterates over all sentences and tokens
of the input text. For each token, it queries available dictionar-
ies or regular expression patterns and accepts positive answers
as valid. Otherwise, it considers sequentially each model’s opinion
regarding whether the current token is a drug entity or not. When-
ever a model positively recognises a drug-name, we store the name
along with the conﬁdence of the prediction in a map. After consid-
ering the predictions of all models, we  store the positive prediction
with the highest conﬁdence, if such a prediction exists, and proceed
to the next token. Predictions of dictionaries or regular expression
patterns are assigned 100% conﬁdence.
Algorithm 1. Aggregation of predictions
1: List L → []
2: for all Sentences ∈ Text do
3: Map  M → {:prediction:conﬁdence}
4: for all Tokenst ∈ s do
5:  if ∃ dictionary then
6:  if dictionary.predict(t) → POSITIVE then
7:  PUT  M {prediction 1.0}
8:  else
9: for all Modelm → Models do
10:  if m . predict(t) → POSITIVE then
11: STORE {prediction conﬁdence}
12: end if
13: end for
14: PUT M {prediction max-conﬁdence}
15: end if
16: end if
17: end for
18: DROP overlapping/intersecting spans*
19: ADD L M
20: end for
21: return L
* Rules for dropping spans:
- Identical/Intersecting: ﬁrst span is kept
- Contained: Contained spans are dropped
After processing all tokens of a sentence, any intersecting or
overlapping spans are removed according to the following rules.
For predictions that cross into each-other, we discard all but the
ﬁrst one. For nested predictions, only the maximal one is kept. Upon
algorithm completion, L should contain a sequence of maps, each
representing the predictions on a single sentence.
At a second experimental stage, we de-constructed the dictio-
nary into 2 distinct models: (a) a model trained on text solely
annotated by the dictionary, and (b) an evolved set of string-
patterns that attempts to accurately cover common sufﬁxes of
single-token drug names.
For evaluation, we used the standard information retrieval
metrics: precision, recall and F-score (F1) [42].
3.2. Data
The proposed method requires two  types of resources: (a) one
or more comprehensive lexical repositories, such as dictionaries or
lexicons. (b) large amounts of raw text in the domain of interest,
which is drugs for the current study. Supplementally, a small gold-
standard corpus may  enhance NER performance if available.Our method could potentially be applied to recognise any type
of biomedical NEs, such as genes and proteins. We  choose to focus
on identifying drug names, as this domain has been studied to a
much smaller extent. In this section, we present the resources that
1 lligence in Medicine 65 (2015) 145–153
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Table 2
Results of baseline classiﬁers trained on gold-standard data (P: precision, R: recall,
F1: F-score).
Classiﬁer P R F1
Dictionary 99.7% 78.5% 87.8%
Dictionary + synonyms 93.4% 78.9% 85.6%
MaxEnt (gold) 98.3% 84.5% 91.0%
Perceptron (gold) 97.5% 72.0% 82.8%
essentially reﬂects lack of enough training data. Ideally, we  would
need more gold-standard annotations, however, as discussed pre-
viously, this is not always feasible.
Table 3
Results of the best performing systems (in terms of exact-matching F-score) in
general and branded drug name recognition in the DDIExtraction 2013 task [16].
Category General drug names Branded drug names
System NLM LHC [16] UTurku [15]
Team National Library of Medicine University of Turku48 I. Korkontzelos et al. / Artiﬁcial Inte
e made available to the algorithm proposed in Section 3.1 for
xperimentation.
.2.1. DrugBank
As our dictionary, we chose to use DrugBank [4] because it is rel-
tively up-to-date and provides a mapping between drug-names
nd common synonyms. DrugBank currently contains more than
700 entries including 1447 FDA-approved small molecule drugs,
31 FDA-approved biotech (protein/peptide) drugs, 85 nutraceuti-
als and 5080 experimental drugs. We  pre-processed the dictionary
y normalising all ofﬁcial drug terms and linked them to their
ynonyms in a key-value data-structure. Each key (drug name) is
nique and maps to a single value (a list of synonyms).
.2.2. The pharmacokinetic corpus
The pharmacokinetic corpus (PK) [5] is manually annotated
nd consists of 240 MEDLINE abstracts annotated and labelled on
he basis of MESH terms relevant to pharmacokinetics such as
rug names, enzyme names and pharmacokinetic parameters, e.g.
learance. Half of the corpus is intended for training (in vivo/in
itro-train) and half for testing (in vivo/in vitro-test). It is freely
vailable at: rweb.compbio.iupui.edu/corpus (accessed: 15 April
015). As a pre-processing step, all annotations concerning enti-
ies other than drugs were removed, since this study is concerned
ith detecting drug names only.
.2.3. Raw text
Nowadays, acquiring large amounts of raw text is not a difﬁcult
ask, even for very specialised domains. Public electronic reposi-
ories of open-access articles exist for most scientiﬁc domains and
sually can be queried via RESTful web services. In biomedicine, for
xample, UK PubMed Central (UKPMC, europepmc.org, accessed:
5 April 2015) is an article database which extends the functional-
ty of the original PubMed Central (ncbi.nlm.nih.gov/pmc, accessed:
5 April 2015) repository. For the purposes of this study, we used a
mall subset of the entire UKPMC database which includes more
han two million papers. The sample we used was created by
iha˘ila˘ and Navarro [43], totaling 360 pharmacology and cell-
iology related articles. As a pre-processing step, the corpus was
entence-split and tokenised. Part-of-speech tagging was  omitted
rom the process since we  did not plan to use the part-of-speech
ags as features during training.
. Experimental results
The ﬁrst set of experiments, in Section 4.1, considered the entire
et of gold-standard annotations. In the second set, we  assess the
mportance of silver data, i.e. data annotated by recognising dic-
ionary entries on raw text. We  evaluate the performance of our
lassiﬁer trained on silver data only, and we also combine gold
nd silver data to measure whether the combination can boost
erformance. In succession, we investigate how we  can produce
tring similarity patterns based on dictionary knowledge to further
ncrease recall. Finally, we investigate how the proposed aggregate
lassiﬁer performs in absence of gold-standard annotations.
.1. Baselines
Firstly, we tested how the dictionary performs as a single recog-
iser, including or excluding synonyms. Secondly, we  trained two
E recognisers, namely a MaxEnt and a perceptron classiﬁer, on
alf the PK corpus (invivo/invitro-train) and tested them on the
ther half (in vivo/in vitro-test). Finally, we used our prediction
ggregation algorithm to combine predictions originating from the
ictionary, with predictions originating from the classiﬁers.MaxEnt (gold) + dictionary 99.1% 88.4% 93.4%
Perceptron (gold) + dictionary 97.6% 84.3% 90.4%
Table 2 presents the results from our baseline experiments. It
is worth noting that the pure dictionary-based approach is not
100% precise as our voting system assumes. Careful error analysis
revealed that there are at least two  entities, i.e. “nitric oxide” and
“tranylcypromine” that have not been tagged in the gold-standard
corpus. Consequently, the evaluator marks them as false-positives
while, in fact, they are perfectly correct predictions. Another inter-
esting observation is that including synonyms causes precision to
degrade. Synonyms in DrugBank often include acronyms, which
have not been tagged appropriately in the test corpus. As before,
the evaluator classiﬁes them as false-positives.
In general, we can see that both the dictionary and the classiﬁers
exhibit very high precision and good recall, whereas combining
the two  has a minimal positive effect on overall performance.
The perceptron classiﬁer, despite training signiﬁcantly faster,
consistently showed inferior performance in comparison with
MaxEnt.
Unfortunately, no other experimental results on the exact data
that we experimented with have been published. However, to put
our results into perspective, we can consider the results of a recent
evaluation challenge, SemEval-2013 Task 9: DDIExtraction [16].
Its ﬁrst subtask was concerned with recognising and classifying
drug names. Several participating systems aimed at recognising
generic and branded drug names, among other entities. Table 3
show the exact-matching precision, recall and F-score achieved
by the best performing systems in terms of F-score in the cat-
egories of generic and branded drug names. The DDIExtraction
2013 task was evaluated on the DDI corpus, which consists of
784 DrugBank texts and 233 MEDLINE abstracts and was manu-
ally annotated [44]. Although the data used in this work are not
identical to the DDI corpus, the results in Table 3 can be used
as indirect baselines. It can be observed that the our baseline
results in Table 2 are comparable if not slightly better than the best
performing systems the DDIExtraction2013 task, despite the fact
that we  trained on signiﬁcantly smaller and possibly lower-quality
data.
Our baseline experiments show that, despite acquiring state-of-
the-art precision, there is still space for improvement with regards
to recall. High precision indicates that the model extracts some
very informative features while training, whereas not so high recallApproach Dictionary-based SVM classiﬁer (TEES)
Precision 72.5% 94.5%
Recall 91.7% 88.1%
F-score 81.0% 91.2%
I. Korkontzelos et al. / Artiﬁcial Intelligen
Table  4
Results of classiﬁers trained on gold-standard and silver annotation data (P: preci-
sion, R: recall, F1: F-score).
Classiﬁer P R F1
MaxEnt (silver) 98.7% 47.1% 63.7%
MaxEnt (silver) + dictionary 99.2% 78.5% 87.6%
Perceptron (silver) 98.3% 76.9% 86.3%
Perceptron (silver) + dictionary 99.3% 78.5% 87.7%
MaxEnt (gold + silver) 97.8% 84.8% 91.0%
MaxEnt (gold + silver) + dictionary 98.6% 89.7% 93.9%
4
p
d
q
D
d
m
c
t
h
f
s
E
h
ﬁ
a
m
l
o
t
1
T
t
f
e
a
c
m
d
b
[
t
•
•
•
•
•
•
•
f
t
m
l
i
rPerceptron (gold + silver) 97.2% 79.1% 87.2%
Perceptron (gold + silver) + dictionary 98.0% 85.1% 91.1%
.2. Combining heterogeneous models
Attempting to improve recall, we trained separate models
urely on silver data, i.e. data annotated by direct string-matching
ictionary entries. Annotation coverage ultimately depends on the
uality of the dictionary, its coverage and how up-to-date it is.
rugBank is a good candidate for this task, as it is a comprehensive
ictionary of drugs and also freely available. The 360 full papers
entioned in Section 3.2.3 were annotated and partitioned into 30
ollections, each one containing 12 items. This was done in an effort
o incrementally check whether the addition of silver annotations
as any positive or negative effects on classiﬁer’s performance. We
ound that we had to include all 30 partitions in order to witness
ome improvement.
Table 6 summarises the results of our experiments. The Max-
nt classiﬁer trained on silver annotation data achieves marginally
igher precision and signiﬁcantly lower recall than the same classi-
er trained on gold-standard data. This is expected, since the silver
nnotations reﬂect the contents of the dictionary, only. Trained on a
ixture of gold and silver data, the MaxEnt classiﬁer achieves 0.5%
ower precision and 0.3% higher recall than its equivalent trained
n gold-standard data.
Including the dictionary boosts the recall of the MaxEnt classiﬁer
rained on a mixture of gold-standard and silver annotation data by
.3% in comparison with its baseline equivalent. The last 2 rows of
able 4 show that all statistics were slightly boosted just by utilising
hese extra, easy to produce silver annotations.
In all our experiments so far, the best achieved recall is 89.7%,
ar less than precision, thus, we focus on improving it. Careful
xamination of false-negatives reveals that most of them are either
cronyms (e.g. HMR1766), long chemical descriptions (e.g. 5beta-
holestane-3alpha, 7alpha, 12alpha-triol) or terms whose lexical
orphology is particularly different than the usual morphology of
rugs (e.g. grapefruit juice). We  attempted to capture acronyms
y employing a state-of-the-art acronym disambiguator, AcroMine
45], however it did not disambiguate any of the acronyms in ques-
ion, listed below:
ANF
E3174
PO4
RPR 106541
HMR1766
MDZ  4-OH
MDZ  1′-OH
Under data sparsity, it is crucial to extract maximum utility
rom our training set, which necessitates incorporation of fea-
ures with low occurrence frequency. The MaxEnt and perceptron
odels we employ do not consider the uncertainty introduced by
ow frequency training data, hence a frequency threshold value
s introduced to control the compromise between precision and
ecall. For our experiments we set this threshold at 5, as lowerce in Medicine 65 (2015) 145–153 149
values detrimentally affected precision. As discussed, a number of
false-negatives were missed due to their morphology which is dif-
ferent than the usual morphology of drugs. These two facts, suggest
that probably some informative features did not qualify due to the
frequency threshold value. It should be noted that, in contrast to the
MaxEnt classiﬁer, which is probabilistic, the perceptron classiﬁer is
not affected by the frequency threshold. The perceptron is essen-
tially a neural network, thus it does not gather probabilities and
therefore performs best when no frequency threshold is applied.
Beyond the scope of this paper, there are more sophisticated
methods to select important features or tune feature weights to
address data sparsity. In general, two  smoothing approaches [46]
are applied: linear interpolation [47] and back-off models [48–51].
Data sparsity can also be addressed by feature relaxation, based on
hierarchical features [52]. A more sophisticated approach to feature
weighting would be to employ Dirichlet regression [53–55] rather
than MaxEnt. Dirichlet regression considers frequencies directly as
the dependent variable, rather than probabilities as in multinomial
logistic regression. The sum of frequencies for a particular feature
represents its “precision”. It should be noted that for high frequency
data Dirichlet and multinomial logistic regression models behave
similarly.
4.3. Evolving string-similarity patterns
In this section we  aim to improve recall by learning string sim-
ilarity patterns based on dictionary knowledge. Exploring ways to
restore the predictive power the model could have if more train-
ing data were available, we develop a mechanism to deal with
these easy, yet elusive false-negative cases discussed in the previ-
ous section. We  attempt to genetically evolve string patterns that
can then be used as regular expressions to capture drug names
that are not present in the dictionary. We followed a three-step
process described below: genetic programming,  ﬁltering and pattern
augmentation.
Following the work of Tsuruoka et al. [24], we  also use a form of
regression in order to learn common string patterns of drug names.
More speciﬁcally, we used genetic programming, also known as
symbolic regression, a technique which allows the evolution of pro-
grams at the symbolic level [56]. Genetic programming is used in
this task as a global optimisation algorithm.
The pseudo-random sampling inherent in genetic program-
ming means that no hard guarantees about the ﬁnal outcome
can be made. However, the randomness also enables good cov-
erage of the ﬁtness landscape and therefore avoids falling into
local optima, which is essential to solve our problem. Furthermore,
the self-driven nature of evolution is robust as it makes little to
no assumptions about the ﬁtness landscape, thus mitigating bias
during the learning stage, which enables it to produce meaning-
ful solutions where other global optimisation algorithms can falter
[56]. Learning by means of evolution is a good ﬁt for our use-case as
it allows ﬁnding decent solutions with minimal prior knowledge.
Genetic programs assemble variable length program structures
from the basic units, i.e. functions and terminals. The assembly
occurs at the beginning of a run, when the population is initialised.
In succession, programs are transformed using genetic operators,
such as crossover, mutation and reproduction. The algorithm evolves
a population of programs by determining which individuals to
improve based on their ﬁtness, which is in turn assessed by the
ﬁtness-function.
In our implementation, genetic programs were represented as
trees that were traversed in a depth-ﬁrst manner. A ﬁtness function,
a function set and a terminal set are required for developing a genetic
algorithm. Terminals provide the values that can be assigned to the
tree leaves, while functions perform operations on either terminals
or on the output of other functions. Typically, the function set of a
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mage source: [62].
enetic algorithm that deals with numerical calculations contains
he four basic arithmetic operations (+ − * /), while the terminal set
ontains one-digit non-negative integers, [0-9]. In the current case,
he function and terminal sets have to deal with strings. The termi-
al set contains all Latin lowercase letters, [a–z], plus several other
haracters needed for building meaningful regular expressions, i.e.
 \ * + ? () []. The function set contains several string-manipulating
unctions, e.g. split, join and concatenate.
We employed two genetic operators, crossover and mutation. As
llustrated in Fig. 2, tree-based crossover generates new individuals
y swapping subtrees of existing individuals. The population per-
entage applicable to crossover was set to 35%. Mutation typically
perates on one individual. As shown in Fig. 3, a point in the tree
Fig. 3. Example of subtree mutation.
mage source: [62].ce in Medicine 65 (2015) 145–153
under mutation is chosen and the corresponding subtree is replaced
with a new randomly generated subtree. This new subtree is cre-
ated in the same way, and is subject to the same limitations as the
original trees in the initial population. As a matter of future work,
more genetic operators can be employed. Although we  attempt to
employ the simplest genetic operators possible, evolving similar-
ity patterns by genetic programming is the most demanding part
of this work, in terms of computational complexity.
Each “organism” in the genetic population is a small program.
When executed, the program produces a string that is assigned
a score according to the ﬁtness function. For this purpose, all
the single-word terms were extracted from DrugBank and were
used as “test-data” within the ﬁtness function, which returns the
proportion of matches as a measure of ﬁtness. In case the string
produced is not a valid regular expression, the candidate receives
negative score and will most likely be disregarded in the next
generation. For instance, a candidate that matches 50/6700 terms
in DrugBank is obviously ﬁtter than one that matches only 10/6700
terms, which in turn, is ﬁtter than one whose string does not
compile as a regular expression. However, genetic programming
did not achieve anything less than 100% error when attempting
to match entire tokens, and so we  limited the testing scope to the
last 4, 5 or 6 characters of each token. This decision was  made
after observing that word-endings tend to be more similar than
word-beginnings in drug names, mainly for conformance with
the WHO’s international non-proprietary name stem grouping
(who.int/medicines/services/inn/stembook/en, accessed: 15 April
2015). This had a major positive effect on the population in most
executions.
After 200 experiments with 80 generations per experiment and
10,000 individuals per generation, the 30 best-evolved individuals
were selected. Each individual is a function that builds a string that
represents a potentially common sufﬁx, in the form of a regular
expression pattern. The pattern produced by the best individual
matched 7.3% of the terms in the test-set (130 terms). It should be
noted that the evolutionary process evaluates candidates using a
list of singletons and not actual sentences. As a consequence, these
patterns will most likely introduce false-positives if applied directly
on real text, thus, decreasing precision.
In succession, we aim to keep the top performing patterns only,
i.e. the least likely to introduce false-positives. This ﬁltering can be
done either manually or algorithmically. Since the number of pat-
terns is small, the cost of manual checking by a domain expert is
limited. Non-experts could also accomplish this task. Instead, we
chose to increase the applicability of our approach, we selected
the best patterns automatically. We calculated all possible com-
binations of sets of 5 string patterns and performed an extensive
evaluation process where each combination was  evaluated only for
false-positives on 10 randomly selected paragraphs from the orig-
inal training set (PK corpus). We  selected 5 sets of patterns (25
patterns) which introduced the least false-positives. These 25 pat-
terns were reduced to 11 after removing duplicates and those that
would clearly introduce false-positives. For example, the pattern
“m?ine” was removed because it would recognise “ﬂuvoxamine”
correctly, but it would also incorrectly recognise as drugs words
such as “examine”,  “deﬁne”, “jasmine” and “cosine”. Table 5 shows
the 11 best performing patterns, accompanied with the number of
matches and an example for each one, while Fig. 1 shows the tree
that corresponds to the best performing pattern.
Finally, in the pattern augmentation step, we augmented these
11 patterns by wrapping them as follows:\b(\d?\, ?\d′?\−?)?\w+ < pattern > +\b
The string “\ b” at the start and end of the pattern, make it
applicable to whole words only. The string “(\  d?\,?\ d’?\ -?)?\ w+”
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Table  5
Evolved patterns.
Evolved patterns Matches Example
a(z|st|p)ine? 130 Nevirapine
(i|u)dine? 72 Lepirudin
azo(l|n)e? 62 Fluconazole
tamine? 44 Dobutamine
zepam 17 Bromazepam
zolam 13 Haloxazolam
(y|u)lline? 12 Enprofylline
artane? 11 Eprosartan
retine? 10 Hesperetin
navir 9 Saquinavir
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Table 7
Results of classiﬁers that did not use gold-standard data (P: precision, R: recall, F1:
F-score).
Classiﬁer P R F1ocaine 9 Benzocaine
peciﬁes optional triggers, i.e. digits, commas and dashes, mainly
or matching hydroxylated compounds. For example if a pattern
pplies to “midazolam”, it also matches “4-hydroxymidazolam”,
4,5-hydroxymidazolam” and “4,5’-hydroxymidazolam”. It is com-
on  knowledge in biochemistry that all organic compounds go
hrough oxidative degradation when they come in contact with
ir. Hydroxylation is the ﬁrst step in that process and converts
ipophilic compounds into water-soluble (hydrophilic) products
hat are more readily excreted. We  observe many mentions of such
ompounds in pharmacology papers, and therefore we attempt
o capture them with this simple regular expression. The pattern
ugmentation rule, was chosen manually, introducing a minimal
uman interaction in this last step.
The genetic programming paradigm parallels nature in that it
s a never-ending process. In practise however, and particularly
hen evolving code, arbitrary complexity is rarely desired because
t is very easy for the model to over-ﬁt or start deviating substan-
ially from a good solution approximation. We  adopt two  simple
nd widely used termination criteria to address this. We  stopped
he evolution process (a) after a number of iterations (generations)
nd (b) by setting a maximum allowed tree depth (10). The patterns
ere evolved assuming that each will span a single word term.
.4. Evaluation of evolved patterns
We  evaluated the best augmented patterns (Table 5) as a sep-
rate classiﬁcation model. During aggregations, similarly to the
ictionary predictions, positive predictions of the pattern model
re assigned a probability of 100%. Table 6 shows evaluation results.
s a ﬁrst observation, classiﬁer ensembles trained both on gold-
tandard and silver annotation data do not perform better than
lassiﬁer ensembles trained on gold-standard data, only. Combin-
ng the dictionary and the pattern model compensates for the lack
f a lower-quality model both for the MaxEnt and the perceptron
lassiﬁer. Comparing Tables 2, 4 and 6 demonstrates how we  grad-
ally moved from the recall range 84–88% to 89–93%, while keeping
recision above 96–97%. In fact, there are some veriﬁed anno-
ation inconsistencies in the test corpus responsible for a minor
ecrease in precision. More speciﬁcally, some terms, such as 3-
ydroxyquinidine, cycloguanil and 4-hydroxyomeprazole,  have not
een appropriately tagged as drugs.
able 6
valuation results of ensembles that contain the pattern classiﬁer (P: precision, R:
ecall, F1: F-score).
Classiﬁer P R F1
MaxEnt (gold) + dictionary + patterns 97.3% 93.0% 95.1%
MaxEnt (gold + silver) + dictionary + patterns 97.3% 93.0% 95.1%
Perceptron (gold) + dictionary + patterns 95.8% 88.9% 92.3%
Perceptron (gold + silver) + dictionary + patterns 96.0% 88.8% 92.3%MaxEnt (silver) + dictionary + patterns 97.4% 85.4% 91.0%
Perceptron (silver) + dictionary + patterns 97.3% 85.1% 90.8%
4.5. Ignoring gold-standard data
In our experiments so far, we  assumed that at least some gold-
standard data is available for training. However this might not
always be the case. In this section, we  are concerned with the
question: “How much worse would results be, in the absence of a
gold-standard training set?” This is an important question because,
as discussed earlier, gold-standard annotations are time consum-
ing and costly. Ignoring expensive annotations, we experiment
with classiﬁers trained on the easy-to-produce automatically gen-
erated annotations, the dictionary and the pattern model. The same
gold-standard corpus was  used for testing and each incremental
improvement was  also tested for statistical signiﬁcance against the
previous one using chi-square test, with and without Yate’s cor-
rection. In all cases, improvements were found to be statistically
signiﬁcant with p-values ranging from 10−4 to 4 × 10−4. The results
obtained are shown in Table 7.
Comparing these results with the ones from our baseline exper-
iments, presented in Table 2, shows that the MaxEnt classiﬁer
trained solely on silver annotation data, combined with the dic-
tionary and the pattern model, achieves similar performance to
the MaxEnt classiﬁer trained on gold-standard data. This result is
encouraging, since it suggests that access to gold-standard data is
not necessarily a prerequisite for high performance drug-NER.
5. Discussion
Using a lexical database to annotate NEs in raw text is not a new
concept. In fact, since lexical databases are manually annotated,
annotating sentences for NEs from scratch certainly contains some
level of effort duplication. We  attempted to automate the annota-
tion process by utilising such resources. Unfortunately, our results
show that using a dictionary as a direct annotator of drug names
achieves top precision but limited recall. Classiﬁers trained on gold-
standard annotations achieved comparable precision but much
higher recall.
For these reasons, we attempted to experiment with methods to
pre-process DrugBank before using it as an annotator. To increase
recall we  generalised dictionary entries into regular expression
patterns. We  were expecting that the patterns would be able to
capture drug names that were not listed in the dictionary but share
common morphological characteristics, such as sufﬁxes or preﬁxes,
with some dictionary entries.
Obtaining such patterns automatically and accurately is hard
and, thus, our list of patterns is neither perfect nor complete.
Perhaps a pharmacologist cooperating with a regular-expression
expert would ﬁnd higher quality patterns, i.e. patterns that gen-
eralise better. However, we prefer to explore the extent to which
automatic methods can address this task adequately. In the future it
would be very interesting to compare our automated method with
expert-driven regular expressions, together with incorporation of
rules derived from existing WHO  and FDA drug nomenclature pro-
cesses.
Throughout our experiments, we relied heavily on the pro-
posed algorithm for aggregating predictions, which is also not
perfect. It is based on assumptions that may not hold in a
different context. Moreover, the algorithm always favours pre-
dictions of the knowledge-based models (dictionaries and regular
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xpressions) against learning models, accepting the inconsistencies
f knowledge-based models as valid. The manually constructed dic-
ionary was of major importance for this study, as it was used in
 number of ways. It was the basis to extract synonyms, common
ord-ending patterns, and was also seen as a direct annotator for
n entire corpus. Voting systems similar to the proposed prediction
ggregation algorithm are becoming increasingly popular mainly to
oost performance but also for the overall stability of the resulting
lassiﬁer [57–61].
It is also noteworthy that both sets of gold-standard data, for
raining and testing, are of roughly the same size. Contrasting this
ith other similar NER experiments, we ﬁnd that the testing-set is
sually a lot smaller than the training-set regardless of the evalu-
tion scheme (holdout or cross-validation). This is due to the fact
hat the problem of data-sparsity is pervasive across the entire text
ining and NLP discipline (with regards to probabilistic training).
n practice, this means that there is rarely enough training data,
hus splitting it in two equally sized pieces will most likely not lead
o satisfying statistics. We  decided to leave the data as is, in order
or the experiments to be as easily reproducible as possible.
Our results demonstrate that, even though availability of gold-
tandard data is certainly helpful, it is not a strict requirement
ith regards to drug NER. Drugs often share several morpholog-
cal characteristics, which reduces the contextual information that
s needed in order to make informed predictions. Nonetheless, it
emains to be investigated whether our combination of heteroge-
eous models will achieve high performance when tested against
arger corpora.
. Conclusions and future work
This study mainly focused on achieving high performance drug
ER with very limited or no manual annotations. We  achieved this
y merging predictions from several heterogeneous models includ-
ng models trained on gold-standard data, models trained on silver
nnotation data, DrugBank and, ﬁnally, evolved regular expression
atterns. We have shown that state-of-the-art performance in drug
ER is within reach, even in the presence of data sparsity.
Our experiments also show that combining heterogeneous
odels can achieve similar or comparable classiﬁcation per-
ormance with that of our best performing model trained on
old-standard annotations. We  have shown that in the pharma-
ology domain, static knowledge resources such as dictionaries
ctually contain more information than is immediately apparent,
nd therefore can be utilised in other, non-static contexts (i.e.
o devise high-precision regular expression patterns). Including
ynonyms in the dictionary or disambiguating acronyms did not
mprove results in this study mainly due to certain design deci-
ions that surround the PK corpus. More speciﬁcally, none of the
agged acronyms were identiﬁed by AcroMine, whereas most of
he identiﬁed synonyms have simply not been tagged appropri-
tely in the test-set. Generally speaking however, we would expect
 signiﬁcant performance boost from applying these methods.
We plan to extend this work in the future. First of all, we  plan
o take advantage of all the annotations in the PK corpus. Being
ble to recognise both drugs and drug-targets is essential for the
ask of identifying relationships and interactions between them.
e are also very interested to see if we can improve on, or ﬁnd more
ccurate regular expression patterns in order to enrich our “safety
et” model. Moreover, choosing a drug name is a very long and
ostly process, and therefore generating good quality candidates
utomatically would be very useful. Finally, we would like to extend
ur prediction–aggregation algorithm so as to assign probabilities
o predictions of the knowledge-based models (dictionaries and
egular expressions).
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